Silence Therapeutics Plc (SLN)
Silence Therapeutics Market Cap: 277.03M for Jan. 14, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Biodexa Pharmaceuticals Plc | 1.774M |
| Autolus Therapeutics Plc | 379.25M |
| Mereo BioPharma Group Plc | 110.12M |
| NuCana Plc | 14.23M |
| Bicycle Therapeutics Plc | 457.13M |
Market Cap Related Metrics
| PS Ratio | 137.57 |
| PEG Ratio | -0.0252 |
| Price to Book Value | 3.740 |
| Price | 5.865 |
| Earnings Yield | -40.57% |
| PEGY Ratio | -0.0252 |